• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Biotechnology Index NYSE ETF (NY: FBT )

    168.60 -1.13 (-0.67%)
    Streaming Delayed Price Updated: 11:23 AM EDT, Sep 25, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 5,688
    Open 169.96
    Bid (Size) 168.57 (1)
    Ask (Size) 168.77 (4)
    Prev. Close 169.73
    Today's Range 168.41 - 169.96
    52wk Range 130.27 - 174.29
    Shares Outstanding 69,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention
    U.S. Attorney General Merrick Garland said that the Justice Department would file an appeal with the U.S. Supreme Court seeking to block the entirety of Kacsmaryk's order suspending the FDA approval of... 
    Via Benzinga
    Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules
    A U.S. federal appeals court has temporarily blocked a decision by a Texas judge to halt the FDA's approval of a widely used abortion drug. 
    Via Benzinga

    Performance

    YTD
    +5.24%
    +5.24%
    1 Month
    -0.96%
    -0.96%
    3 Month
    +7.97%
    +7.97%
    6 Month
    +10.16%
    +10.16%
    1 Year
    +15.73%
    +15.73%

    More News

    Read More
    New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications
    Via Benzinga
    Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead
    Via Benzinga
    FDA Withdraws Lone Premature Birth Drug Makena Over Lack of Proven Benefits
    Via Benzinga
    US Judge Weighs Nationwide Ban On Abortion Pills
    Via Benzinga
    FDA Takes Action To Restrict Unlawful Import Of Animal Tranquilizer 'Tranq' Or ''Zombie Drug'
    Via Benzinga
    Lots Of & Increasing Evidence That Stocks Are Bottoming For Now
    Via Talk Markets
    How do Biotechnology Funds and ETFs Perform Over Five Years?
    Via Talk Markets
    Biotech ETFs That Outperformed Last Week
    Via Talk Markets
    Biotech ETFs To Benefit From Latest Booster Update
    Via Talk Markets
    Exposures COVID-19
    Q2 Growth 'Nothing Short Of Virtuous': Economist
    Via Benzinga
    Exposures COVID-19
    Top-Performing Biotech ETFs of Last Week
    Via Talk Markets
    5 Top ETFs With Exposure To Biogen
    Via Talk Markets
    5 Top ETFs With Exposure To Biogen
    Via Benzinga
    Exposures Product Safety
    Medical Miracles Inside Biotech ETFs
    Via Talk Markets
    Topics Intellectual Property
    Exposures COVID-19 Intellectual Property
    Biotech ETFs To Suffer As US Backs IP Waiver For COVID-19 Vaccines
    Via Talk Markets
    Topics Intellectual Property
    Exposures COVID-19 Intellectual Property
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.